1 |
Akiyama H, Kakiuchi S, Rikitake J, Matsuba H, Sekinada D, Kozuki Y, Iwata N. Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine. IDCases 2021;25:e01245. [PMID: 34381692 DOI: 10.1016/j.idcr.2021.e01245] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
2 |
Abuhelwa Z, Ning Y, Abdulsattar W, Ghazaleh S, Kahlon N, Elsayed A. Romiplostim for SARS-CoV-2 Vaccine Induced Immune Thrombocytopenia. Am J Ther 2021;28:e685-7. [PMID: 34757966 DOI: 10.1097/MJT.0000000000001447] [Reference Citation Analysis]
|
3 |
Yokomichi H, Kojima R, Horiuchi S, Ooka T, Akiyama Y, Miyake K, Mochizuki M, Otawa S, Shinohara R, Yamagata Z; Japan Environment and Children's Study Group. Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study. Vaccine 2021;39:1800-4. [PMID: 33685777 DOI: 10.1016/j.vaccine.2021.02.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Helms JM, Ansteatt KT, Roberts JC, Kamatam S, Foong KS, Labayog JS, Tarantino MD. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med 2021;12:221-4. [PMID: 33854395 DOI: 10.2147/JBM.S307047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
|
5 |
Yokomichi H, Mochizuki M, Yamagata Z. Encouraging Cross-Disciplinary Collaboration and Innovation in Epidemiology in Japan. Front Public Health 2021;9:641882. [PMID: 33869131 DOI: 10.3389/fpubh.2021.641882] [Reference Citation Analysis]
|
6 |
Küster O, Schmohl J, Greiner J, Storz MA. Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report. Eur J Med Res 2022;27:63. [PMID: 35505368 DOI: 10.1186/s40001-022-00686-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|